サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467887

アレルギー治療市場レポート：タイプ別、治療法別、剤形別、流通チャネル別、地域別、2024～2032年

Allergy Treatment Market Report by Type, Treatment, Dosage Form, Distribution Channel, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 136 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
アレルギー治療市場レポート：タイプ別、治療法別、剤形別、流通チャネル別、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアレルギー治療市場規模は2023年に223億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに355億米ドルに達し、2024～2032年の成長率（CAGR）は5.2%になると予測しています。

アレルギー治療とは、花粉、カビ、動物のフケ、ラテックス、昆虫、食物、薬剤などのアレルゲンに対する異常反応を予防的に治療することです。これらは免疫系によるヒスタミンの放出を誘発し、炎症、発疹、かゆみ、くしゃみ、鼻水、目の充血などを引き起こします。また、花粉症、喘息、鼻炎、皮膚アレルギー、食物アレルギー、眼アレルギーなど、さまざまなアレルギー症状を引き起こすこともあります。アレルギーの治療には、経口、吸入、経鼻投与による抗アレルギー薬や免疫療法があります。これらの治療法は、過敏症や炎症を抑え、症状を軽減し、患者の生活の質を向上させるのに役立ちます。

アレルギー治療市場の動向：

世界中で様々なアレルギーの有病率が増加していることが、市場成長を促進する主要要因の1つです。これに伴い、政府や非政府組織（NGO）が、アレルギーの有害性や適切な治療法について大衆を啓発するための積極的な取り組みを行っていることが、市場の成長を後押ししています。さらに、消費者のセルフメディケーション志向の高まりと相まって、一般用医薬品（OTC）の需要が増加していることも成長を促す要因となっています。さらに、アレルギー疾患の診断、的を絞った介入のための患者転帰の予測、免疫学的データの分析、ケア提供の改善のための人工知能（AI）、自然言語処理（NLP）、機械学習（ML）の統合が、市場成長に弾みをつけています。これとは別に、皮下アレルゲン特異的免疫療法（SCIT）の有効性、安全性、免疫系を変化させ全身的な緩和をもたらす能力による需要の増加が、市場に明るい展望を生み出しています。その他の要因としては、多額の医療支出、高齢者人口の増加、新規治療法に向けた広範な研究開発（R&D）活動、喘息の罹患率の上昇などが挙げられ、市場成長の原動力になると予想されます。

本レポートで扱う主要質問

  • 2023年の世界のアレルギー治療市場規模は？
  • 2024～2032年にかけての世界のアレルギー治療市場の予想成長率は？
  • アレルギー治療の世界市場を牽引する主要因は何か？
  • アレルギー治療の世界市場におけるCOVID-19の影響は？
  • アレルギー治療の世界市場のタイプ別区分は？
  • 治療法別のアレルギー治療の世界市場内訳は？
  • アレルギー治療の世界市場における主要地域は？
  • アレルギー治療の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 アレルギー治療の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 眼アレルギー
  • 皮膚アレルギー
  • 食物アレルギー
  • 喘息
  • 鼻炎
  • その他

第7章 市場内訳：治療法別

  • 抗アレルギー剤
  • 免疫療法

第8章 市場内訳：剤形別

  • 経口剤
  • 吸入剤
  • 経鼻剤
  • その他

第9章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン小売業
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • ALK-Abello A/S
    • Allergopharma（Dermapharm AG）
    • Allergy Therapeutics
    • Almirall S.A
    • AstraZeneca plc
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • HAL Allergy Group（Droege International Group）
    • Leti Pharma
    • Nicox S.A.
    • Sanofi S.A.
    • Stallergenes Greer
図表

List of Figures

  • Figure 1: Global: Allergy Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Allergy Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Allergy Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Allergy Treatment Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Allergy Treatment Market: Breakup by Treatment (in %), 2023
  • Figure 6: Global: Allergy Treatment Market: Breakup by Dosage Form (in %), 2023
  • Figure 7: Global: Allergy Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Allergy Treatment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Allergy Treatment (Eye Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Allergy Treatment (Eye Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Allergy Treatment (Skin Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Allergy Treatment (Skin Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Allergy Treatment (Food Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Allergy Treatment (Food Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Allergy Treatment (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Allergy Treatment (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Allergy Treatment (Rhinitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Allergy Treatment (Rhinitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Allergy Treatment (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Allergy Treatment (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Allergy Treatment (Anti-Allergy Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Allergy Treatment (Anti-Allergy Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Allergy Treatment (Immunotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Allergy Treatment (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Allergy Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Allergy Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Allergy Treatment (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Allergy Treatment (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Allergy Treatment (Intranasal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Allergy Treatment (Intranasal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Allergy Treatment (Other Dosage Forms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Allergy Treatment (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Allergy Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Allergy Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Allergy Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Allergy Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Allergy Treatment (Online Retailers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Allergy Treatment (Online Retailers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Allergy Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Allergy Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia-Pacific: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia-Pacific: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Allergy Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Allergy Treatment Market: Breakup by Country (in %), 2023
  • Figure 89: Middle East and Africa: Allergy Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Global: Allergy Treatment Industry: SWOT Analysis
  • Figure 91: Global: Allergy Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Allergy Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Allergy Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Allergy Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Allergy Treatment Market Forecast: Breakup by Treatment (in Million US$), 2024-2032
  • Table 4: Global: Allergy Treatment Market Forecast: Breakup by Dosage Form (in Million US$), 2024-2032
  • Table 5: Global: Allergy Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Allergy Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Allergy Treatment Market: Competitive Structure
  • Table 8: Global: Allergy Treatment Market: Key Players
目次
Product Code: SR112024A6281

The global allergy treatment market size reached US$ 22.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 35.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.

Allergy treatment is a preventive medical cure for abnormal reactions to allergens, such as pollens, molds, animal dander, latex, insects, food, and medications. They trigger the release of histamine by the immune system that causes inflammation, rashes, itchiness, sneezing, runny nose, and red eyes. They can also cause various allergic conditions, including hay fever, asthma, rhinitis, and skin, food, and eye allergies. Allergy treatment includes anti-allergic drugs and immunotherapy that can be administered through oral, inhalers, and intranasal dosage forms. These treatment methods help reduce sensitivity and inflammation, decrease symptoms, and improve the quality of the patient's life.

Allergy Treatment Market Trends:

The increasing prevalence of various allergies across the globe is one of the primary factors driving the market growth. In line with this, favorable initiatives by governments and non-governmental organizations (NGOs) to sensitize the masses about the adversities of allergies and their appropriate treatment options are favoring the market growth. Furthermore, increasing demand for over-the-counter (OTC) drugs, coupled with a growing inclination toward self-medication among consumers, is acting as another growth-inducing factor. Additionally, the integration of artificial intelligence (AI), natural language processing (NLP), and machine learning (ML) for diagnosing allergic diseases, predicting patient outcomes for targeted interventions, analyzing immunological data, and improving care delivery is providing an impetus to market growth. Apart from this, the increasing demand for subcutaneous allergen-specific immunotherapy (SCIT) due to its effectiveness, safety, and ability to alter the immune system and provide systemic relief is creating a positive outlook for the market. Other factors, including significant healthcare expenditures, increasing geriatric population, extensive research and development (R&D) activities towards novel treatments, and rising incidences of asthma, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, treatment, dosage form and distribution channel.

Breakup by Type:

Eye Allergy

Skin Allergy

Food Allergy

Asthma

Rhinitis

Others

Breakup by Treatment:

Anti-Allergy Drugs

Immunotherapy

Breakup by Dosage Form:

Oral

Inhalers

Intranasal

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Retailers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., ALK-Abello A/S, Allergopharma (Dermapharm AG), Allergy Therapeutics, Almirall S.A, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, HAL Allergy Group (Droege International Group), Leti Pharma, Nicox S.A., Sanofi S.A. and Stallergenes Greer.

Key Questions Answered in This Report

  • 1. What was the size of the global allergy treatment market in 2023?
  • 2. What is the expected growth rate of the global allergy treatment market during 2024-2032?
  • 3. What are the key factors driving the global allergy treatment market?
  • 4. What has been the impact of COVID-19 on the global allergy treatment market?
  • 5. What is the breakup of the global allergy treatment market based on the type?
  • 6. What is the breakup of the global allergy treatment market based on the treatment?
  • 7. What are the key regions in the global allergy treatment market?
  • 8. Who are the key players/companies in the global allergy treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Allergy Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Eye Allergy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Skin Allergy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Food Allergy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Asthma
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Rhinitis
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Treatment

  • 7.1 Anti-Allergy Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunotherapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Inhalers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Intranasal
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Retailers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 ALK-Abello A/S
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Allergopharma (Dermapharm AG)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Allergy Therapeutics
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Almirall S.A
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 AstraZeneca plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Bayer AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Boehringer Ingelheim International GmbH
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 HAL Allergy Group (Droege International Group)
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Leti Pharma
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Nicox S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
    • 15.3.13 Stallergenes Greer
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio